Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Bulk Drug Intermediates >  5-BROMOCYTIDINE

5-BROMOCYTIDINE

Basic information Safety Supplier Related

5-BROMOCYTIDINE Basic information

Product Name:
5-BROMOCYTIDINE
Synonyms:
  • 5-BROMOCYTIDINE
  • 5-Bromo-D-cytidine
  • 5-BROMOCYTIDINE, HPLC PURIFIED, 98% PURE WITH HPLC UV CHROMATOGRAM
  • 4-amino-5-bromo-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
  • 5-Br-Cytidine
  • Cytidine, 5-bromo-
  • 5-Br-Cr
  • 4-Amino-5-bromo-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
CAS:
3066-86-2
MF:
C9H12BrN3O5
MW:
322.11
EINECS:
500-100-4
Mol File:
3066-86-2.mol
More
Less

5-BROMOCYTIDINE Chemical Properties

Melting point:
183-185 °C
Boiling point:
555.4±60.0 °C(Predicted)
Density 
2.28±0.1 g/cm3(Predicted)
storage temp. 
Keep in dark place,Inert atmosphere,2-8°C
pka
13.48±0.70(Predicted)
form 
Solid
More
Less

5-BROMOCYTIDINE Usage And Synthesis

Description

5-Bromocytidine is a pyrimidine nucleoside. 5-Bromocytidine is used in the synthesis of substituted cytidine analogs identification of potent inhibitor of viral rnadependent RNA polymerases and has been shown to inhibit the replication of influenza virus in cell culture.

Uses

5-Bromocytidine is a useful research chemical used in the preparation and synthesis of substituted cytidine analogs identification of potent inhibitor of viral rnadependent RNA polymerases.

Synthesis

65-46-3

3066-86-2

The general procedure for the synthesis of 4-amino-5-bromo-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one from cytidine was as follows: using a typical method of bromination of unprotected nucleosides, 1,3-dibromo-5,5-dimethylglycolactonium (DBH, 323 mg, 1.13 mmol ) was added to a stirred solution of cytidine (1d, 500 mg, 2.05 mmol) in N,N-dimethylformamide (DMF, 5 mL). The reaction mixture was stirred at room temperature for 20 min or monitored by thin layer chromatography (TLC) until the starting material completely disappeared and a less polar product was formed. Subsequently, the volatile solvent was evaporated under reduced pressure and the residue was co-evaporated with acetonitrile (MeCN) to remove the residual DMF.The resulting light-colored solid was recrystallized from hot acetone to give the target product 2d (500 mg, 75% yield) as colorless crystals with physicochemical properties consistent with those reported in the literature.

References

[1] Organic and Biomolecular Chemistry, 2014, vol. 12, # 30, p. 5634 - 5644
[2] Synthesis, 2009, # 23, p. 3957 - 3962
[3] Tetrahedron Letters, 2012, vol. 53, # 26, p. 3333 - 3336
[4] Molecules, 2013, vol. 18, # 10, p. 12740 - 12750
[5] Journal of the American Chemical Society, 1995, vol. 117, # 2, p. 704 - 714

5-BROMOCYTIDINESupplier

Panaishen (Henan) Pharmaceutical Science and Technology Co. , Ltd. Gold
Tel
0371-65325800 13700860222
Email
haifeng.zhang@pannacean.com
T&W GROUP
Tel
021-61551611 13296011611
Email
contact@trustwe.com
Hangzhou Sage Chemical Co., Ltd.
Tel
+86057186818502 13588463833
Email
info@sagechem.com
Wuhan Chemduro Pharm Tech Co. Ltd.
Tel
18040571231/1402788087
Finetech Industry Limited
Tel
027-87465837 19945049750
Email
sales@finetechnology-ind.com